| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10968581 | Vaccine | 2012 | 9 Pages |
Abstract
⺠Bacterial meningitis has declined upon use of Hib, PCV and meningococcal conjugate vaccines. ⺠Group B streptococcus accounts for most neonatal bacterial meningitis in USA. ⺠We describe emerging pathogens contributing to the residual disease burden. ⺠We review factors influencing vaccine design and uptake. ⺠We discuss how future vaccines may further reduce bacterial meningitis globally.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Matthew J. Bottomley, Davide Serruto, Marco Aurélio Palazzi Sáfadi, Keith P. Klugman,